Sep 2026
Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis highlights SPP1.
Circulating proteins have been widely investigated as potential biomarkers in multiple sclerosis (MS), yet findings across studies are often inconsistent, likely reflecting differences in disease stage, treatment exposure, and cohort composition. Studying individuals at elevated risk of MS prior to disease onset offers...
Kristin Mounts, Yun-Duo Liu, Masashi Fujita et al.
· Multiple Sclerosis and Relat... · 0 citations